Random Forest for Predicting Treatment Response to Radioiodine and Thyrotropin Suppression Therapy in Patients With Differentiated Thyroid Cancer But Without Structural Disease
The Oncologist · 05.01.2024 · 29 (1) · e68-e80
DOI: 10.1093/oncolo/oyad252 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Oncologist, online erschienen am 05.09.2023. Verfasst von Ri Sa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The First Hospital of Jilin University, Changchun, People's Republic of China. Hauptthemen laut MEDLINE: Iodine Radioisotopes, Thyroid Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China, 13th Youth Development Fund of the hospital.
Abstract (Originalsprache)
Background
We aimed to develop a machine-learning model for predicting treatment response to radioiodine (131I) therapy and thyrotropin (TSH) suppression therapy in patients with differentiated thyroid cancer (DTC) but without structural disease, based on pre-treatment information. Patients and Methods Overall, 597 and 326 patients with DTC but without structural disease were randomly assigned to “training” cohorts for predicting treatment response to 131I therapy and TSH suppression therapy, respectively. Six supervised algorithms, including Logistic Regression, Support Vector Machine, Random Forest (RF), Neural Networks, Adaptive Boosting, and Gradient Boost, were used to predict effective response (ER) to 131I therapy and biochemical remission (BR) to TSH suppression therapy.
Results
Stimulated and suppressed thyroglobulin (Tg) and radioiodine uptake before the current course of 131I therapy were mostly attributed to ER to 131I therapy, while thyroid remnant available on the post-therapeutic whole-body scan at the last course of 131I therapy and TSH were greatly contributed to Tg decline under TSH suppression therapy. RF showed the best performance among all models. The accuracy and area under the receiver operating characteristic curve (AUC) for segregating ER from non-ER during 131I therapy with RF were 81.3% and 0.896, respectively. The accuracy and AUC for predicting BR to TSH suppression therapy with RF were 78.7% and 0.857, respectively.
Conclusion
This study demonstrates that machine learning models, especially the RF algorithm are useful tools that may predict treatment response to 131I therapy and TSH suppression therapy in DTC patients without structural disease based on pre-treatment routine clinical variables and biochemical markers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, The First Hospital of Jilin University, Changchun, People's Republic of China.
Förderung
- Natural Science Foundation of China
- 13th Youth Development Fund of the hospital
Zitieren
APA
Sa, R., Yang, T., Zhang, Z., & Guan, F. (2024). Random Forest for Predicting Treatment Response to Radioiodine and Thyrotropin Suppression Therapy in Patients With Differentiated Thyroid Cancer But Without Structural Disease. The Oncologist, 29(1), e68-e80. https://doi.org/10.1093/oncolo/oyad252
Vancouver
Sa R, Yang T, Zhang Z, Guan F. Random Forest for Predicting Treatment Response to Radioiodine and Thyrotropin Suppression Therapy in Patients With Differentiated Thyroid Cancer But Without Structural Disease. The Oncologist. 2024;29(1):e68-e80. doi:10.1093/oncolo/oyad252
BibTeX
@article{Sa2024,
author = {Sa, Ri and Yang, Taiyu and Zhang, Zexu and Guan, Feng},
title = {Random Forest for Predicting Treatment Response to Radioiodine and Thyrotropin Suppression Therapy in Patients With Differentiated Thyroid Cancer But Without Structural Disease},
journal = {The Oncologist},
year = {2024},
volume = {29},
number = {1},
pages = {e68--e80},
doi = {10.1093/oncolo/oyad252}
}
EUVIMED